Skye Bioscience, Inc. (SKYE) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-04-02

Skye Bioscience, Inc. (SKYE) — no SEC Form 4 insider filings recorded in the last 90 days. 3 Form 8-K material event filings were reported by SKYE in the last 90 days. InsiderAlpha tracks every SKYE SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Skye Bioscience, Inc. (SKYE)

SEC CIK	0001516551

90-Day SEC Filing Activity

Form 8-K filings (90d)	3
Latest Form 4 filing	2026-04-02

Recent SKYE Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2025-08-22	5AM Partners VII, LLC	Insider	S — Open-market sale	164.0K	$3.42	$561K	SEC
2025-08-22	5AM Partners VII, LLC	Insider	S — Open-market sale	6.5K	$3.42	$22K	SEC
2025-08-22	Schwab Andrew J.	Insider	S — Open-market sale	164.0K	$3.42	$561K	SEC
2025-08-22	Schwab Andrew J.	Insider	S — Open-market sale	6.5K	$3.42	$22K	SEC
2025-08-21	Schwab Andrew J.	Insider	S — Open-market sale	58.6K	$3.57	$209K	SEC
2025-08-21	5AM Partners VII, LLC	Insider	S — Open-market sale	2.3K	$3.57	$8K	SEC
2025-08-21	5AM Partners VII, LLC	Insider	S — Open-market sale	58.6K	$3.57	$209K	SEC
2025-08-21	Schwab Andrew J.	Insider	S — Open-market sale	2.3K	$3.57	$8K	SEC
2024-11-18	DHILLON PUNIT	Chief Executive Officer	S — Open-market sale	82.5K	$4.99	$412K	SEC
2024-11-18	Grayson Paul A.	Director	S — Open-market sale	86.2K	$4.99	$430K	SEC
2024-11-18	Diep Tuan Tu	Chief Development Officer	S — Open-market sale	19.5K	$4.99	$97K	SEC
2024-11-18	ARSENAULT KAITLYN	Chief Financial Officer	S — Open-market sale	43.2K	$4.99	$216K	SEC
2024-11-15	ARSENAULT KAITLYN	Chief Financial Officer	S — Open-market sale	190	$5.55	$1K	SEC
2024-11-15	Grayson Paul A.	Director	S — Open-market sale	307	$5.55	$2K	SEC
2024-11-15	Diep Tuan Tu	Chief Development Officer	S — Open-market sale	85	$5.55	$472	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Skye Bioscience, Inc. (SKYE). Updated in real time as new filings are submitted to the SEC.

Recent SKYE Form 8-K Material Events

2026-06-22 — Item 8.01 [SEC]
2026-05-29 — Item 5.03, 5.07, 9.01 [SEC]
2026-05-15 — Item 3.01 [SEC]
2026-04-06 — Item 5.02 · Other · neutral [SEC]
Skye Bioscience filed an 8-K/A amendment to correct a scrivener's error in the original April 3, 2026 8-K filing regarding option repricing. The amendment clarifies that the total number of shares underlying all repriced options is 2,458,158 shares. This is a routine administrati
2026-04-03 — Item 5.02, 9.01 · Leadership · negative [SEC]
Skye Bioscience's Board approved a stock option repricing on March 31, 2026, reducing the exercise price of all outstanding employee stock options (including executive officers) to $0.6150 per share, the closing price on the repricing date. This action affects 2,420,978 shares an

Recent Insider Filings

2026-04-02 — Smith Karen L. (Director)
2026-04-02 — Twitty Christopher (Chief Scientific Officer)
2026-04-02 — Jenkins Annalisa (Director)
2026-04-02 — Charych Deborah H. (Director)
2026-04-02 — Grayson Paul A. (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in SKYE insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

SKYE Insider Trading — FAQ

What is the latest insider trade for SKYE?: Skye Bioscience, Inc. (SKYE) had 0 insider filings in the last 90 days, with the most recent on 2026-04-02. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying SKYE stock?: 0 insider purchases of SKYE were filed in the last 90 days.
How many insiders are selling SKYE stock?: 0 insider sales of SKYE were filed in the last 90 days.
Where can I see SKYE SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every SKYE SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live SKYE dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.